Oran, B., Jorgensen, J. L., Marin, D., Wang, S., Ahmed, S., Alousi, A. M., . . . Champlin, R. E. (2017). Pre-transplantation minimal residual disease with cytogenetic and molecular diagnostic features improves risk stratification in acute myeloid leukemia. Haematologica.
Chicago Stili AlıntıOran, Betül, et al. "Pre-transplantation Minimal Residual Disease With Cytogenetic and Molecular Diagnostic Features Improves Risk Stratification in Acute Myeloid Leukemia." Haematologica 2017.
MLA AlıntıOran, Betül, et al. "Pre-transplantation Minimal Residual Disease With Cytogenetic and Molecular Diagnostic Features Improves Risk Stratification in Acute Myeloid Leukemia." Haematologica 2017.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..